Search results for "Paranoid schizophrenia"

showing 9 items of 9 documents

A telemedicine platform to improve clinical parameters in paranoid schizophrenia patients: Results of a one-year randomized study

2018

Objective The study objective was to test a smartphone-based MONEO platform designed to improve the clinical condition of paranoid schizophrenia patients. Telemedicine treatment is considered to be as effective as traditional treatment in outpatient clinics. Method A total of 290 patients with paranoid schizophrenia in the symptomatic remission state were recruited to this 12-month multicenter, open-label randomized trial. A study group (n = 191) received a smartphone with the MONEO platform installed. Patients conducted cognitive training twice a week. Patients' mental state was assessed every month via teleconference. A placebo group (n = 99) received a platform with functionality limited…

AdultMalemedicine.medical_specialtyTelemedicineParanoid schizophreniaPlacebo grouplaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawOutcome Assessment Health Caremental disordersmedicineHumansOutpatient clinicsmartphone platformparanoid schizophreniaBiological PsychiatrySchizophrenia ParanoidPositive and Negative Syndrome Scaletelephone-based interventionbusiness.industrymedicine.diseaseMobile ApplicationsCognitive RemediationCognitive training030227 psychiatryPsychiatry and Mental healthMental statePhysical therapyFemaleSmartphonetelemedicinebusiness030217 neurology & neurosurgerySchizophrenia Research
researchProduct

Savoxepine: invalidation of an "atypical" neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patien…

1991

The new tetracyclic compound savoxepine exhibits potent antidopaminergic effects with preferential activity in the hippocampus as compared to striatum in rat brain. As a result of behavioural animal models and regional differences in dopamine receptor binding characteristics, it has been suggested to possess an "atypical" neuroleptic response pattern. In an open clinical trial, savoxepine was administered to 12 in-patients suffering from paranoid schizophrenia and schizophreniform disorder (DSM-III). Eight patients were treated with a stable dose of 0.5 mg per day throughout the study, while in the remaining patients higher doses up to 20 mg/day were administered. Mean total BPRS scores and…

AdultMalePsychosisParanoid schizophreniamedicine.medical_treatmentPharmacologyExtrapyramidal symptomsBasal Ganglia DiseasesmedicineHumansSchizophreniform disorderAntipsychoticAgedPharmacologyPsychiatric Status Rating ScalesDopamine antagonistDopamine receptor bindingMiddle Agedmedicine.diseaseEnzymesDisease Models AnimalSchizophreniaDibenzoxazepinesSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologymedicine.drugAntipsychotic AgentsPsychopharmacology
researchProduct

P-869 - „Two great masqueraders” in a psychiatry clinic - case series of neurosyphilis and neuroborreliosis

2012

Background Neurosyphilis can develop at any stage of syphilis despite of previously recieved treatment, and it can mimic any neuropschychiatric disorder. The psychopathology of neuroborreliosis is less described. Objectives To describe the cases of schizophrenia - like psychosis in patients with these hronic neuroinfections. Methods and materials Retrospective chart review study of five inmates (four with neurosyphilis and one with neuroborreliosis) was performed. Results Psychiatric histories of two females (45 and 49 y.o.) and three males (31, 40, 45 y.o.) are achieved. In four cases they were initially misdiagnosed as paranoid schizophrenia and in one case - as a persistent alcoholic hal…

medicine.medical_specialtyPsychosisParanoid schizophreniaPediatricsbusiness.industrymedicine.diseaseAlcoholic hallucinosisNeurosyphilisPsychiatry and Mental healthSchizophreniaMedicineSyphilisbusinessPsychiatryNeuroborreliosisPsychopathologyEuropean Psychiatry
researchProduct

Treatment Compliance in the Long-Term Paranoid Schizophrenia Telemedicine Study

2017

Schizophrenia is a chronic disease with a relatively high relapse rate. Different methods are introduced to improve compliance of the patients treated by psychiatrists; among them, a new and promising attitude is telepsychiatry. The 12-month clinical study of the compliance in paranoid schizophrenia was performed on the group of 199 patients. Every patient in the study was given a smartphone with the preinstalled original telemedicine platform (Telemedicine MoneoPlatform). The telemedicine system recorded every confirmation of the drug intake, and according to that, the compliance was counted as the percent of the doses of medication confirmed in relation to the planned ones. In the first m…

Paranoid schizophreniamedicine.medical_specialtyTelemedicinebusiness.industryTelepsychiatrytelepsychiatrymedicine.diseasecomplianceArticle030227 psychiatryClinical studyschizophrenia03 medical and health sciences0302 clinical medicineChronic diseaseTreatment complianceSchizophreniamental disordersPhysical therapyMedicineDrug intoxicationbusiness030217 neurology & neurosurgeryJournal of Technology in Behavioral Science
researchProduct

Dental implants placement in paranoid squizofrenic patient with obsessive-compulsive disorder: A case report

2017

Background Paranoid schizophrenia is a mental illness that involves no observable anatomical alteration. Main characteristic affects the personality of the individual, as well as areas of his own psychology. Case report A 33-year-old man with paranoid schizophrenia and obsessive-compulsive disorder in treatment with Haloperidol, Oxcarbazepine, Olanzapine and Seroquel is presented. Dental exploration showed widespread decay mostly cervical with numerous root fragments, agenesis of lateral incisors, impacted wisdom teeth, missing teeth and malocclusion. Treatment plan included restoration of teeth decay, extractions of root fragments and implant-supported prostheses in bilateral upper lateral…

Paranoid schizophreniabusiness.industrymedicine.medical_treatmentDentistryCase Report:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseProsthesisOsseointegration030227 psychiatry03 medical and health sciencesstomatognathic diseases0302 clinical medicineUNESCO::CIENCIAS MÉDICASmedicineLocal anesthesia030212 general & internal medicineImplantMalocclusionOral SurgeryImpacted wisdom teethbusinessGeneral DentistryContraindicationJournal of Clinical and Experimental Dentistry
researchProduct

EPA-0424 – Impact of cognitive traning with cognitrain system on cognitive plasticity in schizophrenic patients

2014

Background In the literature we can find an increasing number of examples of successful cognitive rehabilitation of patients suffering from schizophrenia. The aim of this study was to investigate the effectiveness and impact of the CogniTrain therapeutic method on cognitive neuroplasticity in patients suffering from paranoid schizophrenia. We expected an answer to the question, whether brain is sensitive to stress and if the efficiency of cognitive rehabilitation improves as a result of using CogniTrain computer training. Subjects and methods Two groups of test subjects were recruited of patients with paranoid schizophrenia. In the first and second groups the measurements of short-term memo…

Paranoid schizophreniaRehabilitationmedicine.medical_treatmentNeuropsychologyCognitionmedicine.diseaseCognitive trainingPsychiatry and Mental healthCognitive remediation therapymedicineCognitive rehabilitation therapyPsychologyNeurocognitiveClinical psychologyEuropean Psychiatry
researchProduct

Stability in MMPI among adoptees with high and low genetic risk for schizophrenia and with low Communication Deviance of their adoptive parents.

2013

Abstract Stability has been considered an important aspect of vulnerability to schizophrenia. The temporal stability of the scales in the Minnesota Multiphasic Personality Inventory (MMPI) was examined, using adoptees from the Finnish Adoptive Family Study of Schizophrenia. Adoptees who were high-risk (HR) offspring of biological mothers having a schizophrenia spectrum disorder ( n =28) and low-risk (LR) controls ( n =46) were evaluated using 15 MMPI scales at the initial assessment (HR, mean age 24 years; LR, mean age 23 years) and at the follow-up assessment after a mean interval of 11 years. Stability of the MMPI scales was also assessed in the groups of adoptees, assigned according to t…

AdultMaleParentsParanoid schizophreniaAdolescentHostilityAdoption studyEnvironmentDevelopmental psychologyYoung AdultCommunication devianceMinnesota Multiphasic Personality InventoryMMPIPsychoticismmental disordersAdoptionmedicineHumansta515Biological PsychiatryFinlandAnalysis of VarianceCommunicationmedicine.diseasePsychiatry and Mental healthHypomaniaSchizophreniaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologyPersonalityPsychiatry research
researchProduct

The Effect of Smartphone-Based Cognitive Training on the Functional/Cognitive Markers of Schizophrenia: A One-Year Randomized Study

2020

Background: Cognitive impairment is associated with long-term disability that results in the deterioration of both the social and professional status of individuals with schizophrenia. The impact of antipsychotic therapy on cognitive function is insufficient. Cognitive training is therefore proposed as a tool for cognitive rehabilitation in schizophrenia. In this study we investigated the effect of self-administered cognitive training using a smartphone-based application on the cognitive function of paranoid schizophrenia patients focusing on response time, correct answer rate, incorrect answer rate, and fatigability to check, if these functions can be functional markers of successful cogni…

paranoid schizophrenia; cognitive impairment; cognitive training; cognitive markers; functional markers; smartphone application; telephone-based intervention; cognitive remediation therapyParanoid schizophreniamedicine.medical_specialtymedicine.medical_treatmentlcsh:Medicinecognitive markersArticlefunctional markerscognitive training03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationMedicineCognitive skillCognitive rehabilitation therapysmartphone applicationparanoid schizophreniacognitive remediation therapycognitive impairmentRehabilitationbusiness.industrytelephone-based interventionlcsh:RCognitionGeneral Medicinemedicine.diseaseCognitive training030227 psychiatrySchizophreniaCognitive remediation therapybusiness030217 neurology & neurosurgeryJournal of Clinical Medicine
researchProduct

Elevated risperidone serum concentrations during acute inflammation, two cases

2015

Inflammation-mediated changes in drug metabolism may lead to alterations in the absorption, distribution, and clearance of psychotropic drugs and thus elevate drug levels in blood and lead to intoxications. We report about two patients who developed an up to threefold increase of dose-related serum concentrations of risperidone’s active moiety (risperidone plus 9-hydroxyrisperidone) during acute inflammation indicated by elevated C-reactive protein. The two female patients (aged 56 and 38 years, respectively) had the diagnoses of paranoid schizophrenia and schizoaffective disorder. For both patients, there was a close time-dependent parallel fluctuation of drug levels and C-reactive protei…

Adultmedicine.medical_specialtyParanoid schizophreniaSchizoaffective disorderInflammationPharmacokineticsInternal medicinemedicineHumansDistribution (pharmacology)PsychiatryInflammationSchizophrenia ParanoidRisperidonebiologybusiness.industryCytochrome P450Middle AgedRisperidonemedicine.diseasePsychiatry and Mental healthC-Reactive ProteinEndocrinologyPsychotic DisordersAcute Diseasebiology.proteinFemalemedicine.symptombusinessDrug metabolismAntipsychotic Agentsmedicine.drugThe International Journal of Psychiatry in Medicine
researchProduct